February 20, 2007Open Access

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Tumour-associated changes have been observed in the circulating nucleic acids of cancer patients and have been proposed to be useful for the detection and monitoring of cancers. In this review, different approaches for detecting tumour-associated nucleic acids in the circulation and their potential applications as tumour markers are discussed.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Chan et al. (Tue,) studied this question.

synapsesocial.com/papers/6a1a781137bfaf0f59459dad https://doi.org/https://doi.org/10.1038/sj.bjc.6603625

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Reduced Plasma RNA Integrity in Nasopharyngeal Carcinoma Patients2006 · 31 citations
2Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study2006 · 47 citations
3Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients2009 · 725 citations
4Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in Serum2006 · 352 citations
5Investigation into the Origin and Tumoral Mass Correlation of Plasma Epstein–Barr Virus DNA in Nasopharyngeal Carcinoma2005 · 57 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo